SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GenSpera, Inc.
An SI Board Since June 2014
Posts SubjectMarks Bans Symbol
9 1 0 GNSZ
Emcee:  roger wilco Type:  Moderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9GenSpera Announces Completion of Patient Enrollment in the Phase II Clinical Triroger wilco-11/6/2014
8GenSpera to Present at Rodman & Renshaw 16th Annual Global Investment Conferroger wilco-8/14/2014
7Majority of HCC Patients In GenSpera’s Trial of G-202 Show Disease Stabilizationroger wilco-7/18/2014
6GenSpera Presents G-202 HCC Clinical Trial Update at 5th Asia-Pacific Primary Liroger wilco-7/15/2014
5GenSpera To Present Ongoing HCC Trial Data at APPLE 2014 Congress July 12th in Troger wilco-7/7/2014
4Media Advisory: GenSpera 2014 BIO International Presentation Available [graphicroger wilco-6/30/2014
3GNSZ news just out! GenSpera Releases 2014 BIO International Presentation and roger wilco-6/24/2014
2GNSZ News and Video June 23, 2014 GenSpera, Inc. (GNSZ) Releases Updated Corporroger wilco-6/23/2014
1GNSZ news! June 19th. 2014 GenSpera CEO, Craig Dionne, to Present Update on Learoger wilco-6/19/2014
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News